We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





EUROMEDLAB 2022 Showcases Breakthrough Technologies and Cutting Edge Scientific Advances in Clinical Lab Diagnostics

By Carolyn Moody, RN - News Editor
Posted on 11 Apr 2022
Print article
Image: EUROMEDLAB 2022 was held 10th-14th April 2022 in Munich (Photo courtesy of IFCC)
Image: EUROMEDLAB 2022 was held 10th-14th April 2022 in Munich (Photo courtesy of IFCC)

The 24th European Congress of Clinical Chemistry and Laboratory Medicine (EUROMEDLAB 2022) saw exhibitors displaying innovations in clinical laboratory diagnostic technologies and offering attendees a hands-on experience with the latest instruments, machines and equipment. The five-day event held from 10th-14th April 2022 in Munich, Germany brought together scientists, laboratory specialists, clinicians, and industry participants in the field of clinical chemistry and laboratory medicine. The show attracted more than 3,000 active participants from across the world, and a number of international speakers and key opinion leaders were invited to address front-edge topics in diagnostic technologies, health care and scientific advances. Among the attendees were private and hospital laboratories, biologists, technicians, biomedical engineers and students.

Following its biannual pattern, EUROMEDLAB had originally been scheduled to take place in late November 2021. However, due to the critical pandemic situation at the venue – Munich in Bavaria, Germany – at that time, the congress was postponed to 10th-14th April 2022, prioritizing the health and safety of all visitors and exhibitors over other aspects. The congress was a hybrid event, with selected symposia and the opening and closing ceremony also held virtually. All COVID-19 restrictions to enter the Congress Centre had been cancelled, allowing all participants and visitors to freely access the Congress Centre and visit EUROMEDLAB. The importance of the live experience was reflected in the impressive reservation numbers. The floorspace of the 10,000-m2 Hall C1 and the ICM foyer was completely sold out and the number of research projects increased as compared to EUROMEDLAB 2020 with a total of 900 scientists submitting their abstracts as compared to 720 for the previous event. As such, the congress continued to grow in importance as a European hotspot for the science industry.

During the congress, attendees were able to experience the outstanding scientific program, which featured innovative and diverse educational opportunities that incorporated the best of clinical laboratory medicine and in vitro diagnostics, including lectures, symposia, recent advancements in clinical practice and science, poster presentations, and much more. A broad range of international speakers, key opinion leaders and stakeholders brought front-edge topics in health care, diagnostic technologies, scientific advances and professional matters to life. Special emphasis was placed on technological advancements, as the meeting aimed to connect the latest technological breakthroughs in diagnostic laboratory technology with the best minds in laboratory medicine to help attendees learn and implement the latest and greatest in clinical laboratory science, technology, and medicine. Attendees were also able to access a lively industry exhibition floor featuring the latest products and developments in diagnostic technologies brought by leading manufacturers. For those who were unable to able to attend the event in person, the show offered a brand-new format of interacting virtually with companies during the conference through the “Exhibition Floor Walks.”

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Liquid Ready-To-Use Lp(a) Reagent
Lipoprotein (a) Reagent

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.